Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Canada Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20043
20062
20071
20084
20091
20102
20113
20123
20131
20163
20171
20191
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated5
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Otsuka Pharmaceutical Development & Commercialization, Inc.5
University of British Columbia3
ACADIA Pharmaceuticals Inc.2
Boehringer Ingelheim2
FORUM Pharmaceuticals Inc2
H. Lundbeck A/S2
Hoffmann-La Roche2
Solvay Pharmaceuticals2
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia32
Psychotic Disorders7
Bipolar Disorder3
Cognition Disorders2
Anxiety Disorders1
Autistic Disorder1
Body Weight Changes1
Mental Disorders1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.